Female Hair Thinning — What the Blood Work Shows

Female hair loss rarely looks like male hair loss, and it is frequently missed because of it. The hairline stays where it is while the part slowly widens — and the blood work that follows does not diagnose the pattern. It identifies what is making it worse.

The Part Widens, The Hairline Holds

Women with pattern hair loss almost always keep their frontal hairline. What changes is the density behind it — the central scalp thins progressively, and the midline part becomes wider each year until scalp is visible through it in overhead light.

The most reliable way to see it is comparison rather than inspection. Part the hair at the midline and part it again at the back of the head, then compare the two widths. In pattern loss the midline part is measurably wider than the occipital part, because the occiput is not androgen-sensitive and has not thinned. This comparison is often the first objective evidence a patient has that something has genuinely changed.

Patients describe it in practical terms rather than clinical ones. The ponytail is thinner in the hand. Hair takes fewer turns of the elastic. The scalp shows in photographs taken under downlights. These observations are accurate, and the female pattern of thinning is usually well established by the time they are made.

Why The Pattern Differs

The underlying process is the same as in men — follicles sensitive to androgens produce progressively finer, shorter hairs with each successive cycle. What differs is the distribution of that sensitivity across the scalp and the hormonal environment it operates in.

In women the frontal hairline follicles are generally less affected, so recession does not occur, while the central scalp miniaturises diffusely. The result is a thinning field rather than a receding line, which is far harder to notice early and far easier to dismiss as normal variation or as a styling problem.

The corollary is that the most obvious sign of male loss is absent, so women frequently present years later than men with the same degree of follicular change. That delay matters because miniaturisation is progressive and because therapy holds ground more effectively than it regains it.

Iron Studies And What Ferritin Means

Iron is the investigation that most often changes management. Ferritin reflects the body's iron stores, and stores can be substantially depleted long before haemoglobin falls — so a woman can have an entirely normal full blood count and still be functionally iron deficient.

That matters for hair because the follicle is one of the most metabolically demanding structures in the body, and it is not a priority organ. When iron availability falls, the follicle is deprioritised before anything essential is, and increased shedding follows. Menstrual loss, pregnancy, vegetarian and vegan diets, restricted eating and gastrointestinal causes are the usual explanations.

Ferritin is also an acute phase reactant, meaning it rises with inflammation and can appear falsely reassuring. This is why it is interpreted alongside the rest of the iron studies and the full blood count rather than as a single number. The association between low iron stores and shedding is strongest in the diffuse shedding pattern rather than in pattern loss itself, and the two frequently coexist.

Thyroid Function

Both an underactive and an overactive thyroid cause diffuse hair loss, and both are common enough in women that thyroid function is checked in almost any woman presenting with diffuse thinning. The mechanism is metabolic — thyroid hormone regulates the hair cycle directly, and disturbance in either direction disrupts it.

Hypothyroidism produces hair that is diffusely thin, dry and coarse, often with lateral eyebrow thinning, alongside fatigue, cold intolerance, weight gain and constipation. Hyperthyroidism produces fine, soft diffuse thinning with heat intolerance, palpitations, weight loss and anxiety. Neither is diagnosed from the hair, but hair loss is sometimes the symptom that prompts the test.

Correcting thyroid dysfunction improves the hair, though not immediately — the cycle takes months to normalise after the hormone levels do, and patients whose thyroid has been treated frequently report that the hair was the last thing to recover. That lag is worth stating in advance, because otherwise it reads as treatment failure.

The Rest Of The Panel, And Its Limits

Beyond iron and thyroid, investigation is directed by the history rather than ordered as a block. A full blood count identifies anaemia and gives context to the ferritin. Where the history includes irregular periods, acne, unwanted facial hair or a suspicion of an underlying endocrine disorder, hormonal investigation is appropriate and may warrant referral.

Vitamin D is frequently measured and frequently low, and its relationship with hair loss is less clear-cut than the marketing around it suggests. Correcting a genuine deficiency is worth doing on its own merits. Attributing a widening part to it is not supportable.

The limit of blood work should be stated clearly: it does not diagnose female pattern hair loss. There is no test for it. Blood work identifies contributors — a deficiency worth correcting, a thyroid disorder worth treating, a shedding event with an explanation. The pattern itself is a clinical diagnosis made by examining the scalp, which is why the four conditions that resemble each other are separated at the examination rather than by a panel.

What The Examination Adds

Calibre variability is looked for first. Under magnification, pattern loss shows terminal, intermediate and fine vellus hairs intermixed across the affected central zone, because individual follicles are at different stages of miniaturisation. Uniform calibre across a thinned area argues against it and points toward a shedding process instead.

Part width is compared midline against occiput, as described. Follicular ostia are checked to exclude a scarring process, and the scalp is examined for perifollicular erythema or scale that would suggest inflammation rather than androgen sensitivity. A gentle pull test estimates how much active shedding is occurring on top of the thinning.

The combination is what produces a usable answer. A woman with a widening midline part, mixed hair calibres, intact ostia and a negative pull test has pattern loss and probably no active effluvium. A woman with uniform calibre, a positive pull test and normal part comparison has a shedding event, and the blood work is looking for its cause. The management that follows differs entirely, and whether medical therapy is appropriate is decided there.

What Supplements Can And Cannot Do

Correcting a demonstrated deficiency helps. If ferritin is low and is raised into an adequate range, shedding attributable to that deficiency reduces. If thyroid dysfunction is treated, the cycle normalises. These are real effects with a clear mechanism, and they are the reason the tests are done.

Supplementing in the absence of a deficiency does not produce the same benefit, and the honest position is that most hair supplements sold for general use have not been shown to alter the course of pattern hair loss. Some carry risk in excess — high-dose vitamin A and selenium are both associated with hair loss when overdone, which is an uncomfortable outcome for a product taken to prevent it.

Nor does correcting a deficiency reverse miniaturisation. A woman with both iron deficiency and pattern loss who raises her ferritin will shed less; her part will still be wider than her occipital part, because androgen-driven miniaturisation is a separate process running underneath. Both are managed, separately, on their own evidence — and that is the framing used when female hair loss is discussed at the first appointment rather than at the third.